PATH | VRL
Menu

Find resources

Total results with these characteristics: 388

Topic: Vaccine safety and performance

Page 8 of 20
Immunogenicity of Quadrivalent HPV Vaccine Among Girls 11 to 13 Years of Age Vaccinated Using Alternative Dosing Schedules: Results 29 to 32 Months After Third Dose

This article, published in the Journal of Infectious Diseases, reports on a study to examine whether immune responses from alternative human papillomavirus (HPV) vaccine schedules are noninferior to the standard schedule two years after …

Author: LaMontagne DS, Thiem VD, Huong VM, Tang Y, Neuzil KM

Publication date: 2013

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-World Experience

This article, published in Clinical Infectious Diseases, reports on a study that assessed the global effect of quadrivalent human papillomavirus (HPV) vaccination on HPV infection and disease. The authors found that over the last decade, the impact …

Author: Garland SM, Kjaer SK, Muñoz N, et al.

Publication date: 2016

The Impact of 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review

This article, published in Advances in Therapy, describes results from a literature review of 37 articles from Australia, western Europe, and North America reporting impact data on invasive pneumococcal disease (IPD) following the introduction of …

Author: Myint TTH, Madhava H, Balmer P, et al.

Publication date: 2013

Impact of Different Dosing Schedules on the Immunogenicity of the Human Rotavirus Vaccine in Infants in Pakistan: A Randomized Trial

This article, published in the Journal of Infectious Diseases, reports the results of a study examining the immunogenicity and efficacy of admininstering an additional dose of monovalent rotavirus vaccine in Pakistan. The authors found that a third …

Author: Ali SA, Kazi AM, Cortese MM, et al.

Publication date: 2014

Impact of Pneumococcal Conjugate Vaccines on Nasopharyngeal Carriage and Invasive Disease Among Unvaccinated People: Review of Evidence on Indirect Effects

This article, published in Vaccine, summarizes the evidence for the indirect effect of pneumococcal conjugate vaccine on vaccine-type pneumococcal disease and its correlation with changes in carriage among unvaccinated populations.

Author: Davis SM, Deloria-Knoll M, Kassa HT, O'Brien KL

Publication date: 2013

The Impact of Protein-Conjugate Polysaccharide Vaccines: An Endgame for Meningitis?

The impact of conjugate polysaccharide vaccines on disease is largely due to their effectiveness against asymptomatic carriage of bacteria. This reduces transmission, resulting in herd immunity; however, the effect on carriage can result in the …

Author: Maiden MCJ

Publication date: 2013

Impact of Rotavirus Vaccination in Australian Children Below 5 Years of Age: A Database Study

This article, published in Human Vaccines & Immunotherapeutics, reports on a study that compared rotavirus hospitalization rates in children less than five years of age before and after the introduction of the rotavirus vaccine Rotarix® in …

Author: Pendleton A, Galic M, Clarke C, et al.

Publication date: 2013

Impact of Rotavirus Vaccination in Germany: Rotavirus Surveillance, Hospitalization, Side Effects and Comparison of Vaccines

This article, published in the Pediatric Infectious Disease Journal, examines the impact of national introduction of rotavirus vaccination in Germany. Rotavirus-related hospital admissions of children under one year of age decreased by 60 percent in …

Author: Uhlig U, Kostev K, Schuster V, Koletzko S, Uhlig HH

Publication date: 2014

Impact of Rotavirus Vaccine on All-Cause Diarrhea and Rotavirus Hospitalizations in Madagascar

This article, published in Vaccine, reports on an observational study which found that after implementation of rotavirus vaccine introduction in Madagascar in 2014, diarrhea hospitalizations in children younger than five years of age decreased by 36 …

Author: Rahajamanana VL, Raboba JL, Rakotozanany A, et al.

Publication date: 2017

Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization Following Introduction Into the South African Public Immunization Program

This article, published in the Pediatric Infectious Disease Journal, describes a study in South Africa that demonstrated dramatic decreases in diarrhea-related hospitalizations in infants and young children in both rural and urban settings in the …

Author: Msimang VMY, Page N, Groome MJ, et al.

Publication date: 2013

Impact of the Introduction of Pneumococcal Conjugate Vaccination on Pneumonia in The Gambia: Population-Based Surveillance and Case-Control Studies

This article, published in The Lancet Infectious Diseases, assessed the impact and effectiveness of routine infant vaccination with pneumococcal conjugate vaccines (PCV) on pneumonia in children in The Gambia, a low-income country with a high burden …

Author: Mackenzie GA, Hill PC, Sahito SM, et al.

Publication date: 2017

Impact of Withholding Breastfeeding at the Time of Vaccination on the Immunogenicity of Oral Rotavirus Vaccine—A Randomized Trial

This article, published in PLOS One, reports on the results of a study that examined the immune effect of withholding breastfeeding one hour before and after administration of the live, oral, monovalent rotavirus vaccine, Rotarix®, in infants in …

Author: Ali A, Kazi AM, Cortese MM, et al.

Publication date: 2015

Incidence of Rotavirus and Circulating Genotypes in Northeast Brazil During 7 Years of National Rotavirus Vaccination

This article, published in PLoS One, examined rates of rotavirus infection before and after rotavirus vaccine introduction in Brazil in 2006. The authors found that the vaccine was associated with substantial reductions in rotavirus incidence and …

Author: Gurgel RQ, Alvarez AJ, Rodrigues A, et al.

Publication date: 2014

The Infant Gut Microbiome Correlates Significantly With Rotavirus Vaccine Response in Rural Ghana

This article, published in the Journal of Infectious Diseases, reports the results of a study examining the differences in intestinal microbiome composition and rotavirus vaccine efficacy in developing-country settings. The authors found that the …

Author: Harris VC, Armah G, Fuentes S, et al.

Publication date: 2016

Influenza Vaccination of Pregnant Women and Protection of Their Infants

This article, published in the New England Journal of Medicine, presents results from two double-blind, randomized, placebo-controlled trials of trivalent inactivated influenza vaccine (IIV3) in South Africa during 2011 in pregnant women infected …

Author: Madhi SA, Cutland CL, Kuwanda L, et al.

Publication date: 2014

Influenza Vaccine Effectiveness in the United States During the 2015–2016 Season

This article, published in The New England Journal of Medicine, reports the results of a study to examine the effectiveness of the live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) formulations used in the 2015–2016 …

Author: Jackson ML, Chung JR, Jackson LA, et al.

Publication date: 2017

Influenza Vaccine for Pregnant Women in Resource-Constrained Countries: A Review of the Evidence to Inform Policy Decisions

While influenza vaccination of pregnant women may be justified on the basis of preventing maternal disease alone, demonstrating additional benefits to the newborn is important to inform policy decisions in areas with limited resources and many …

Author: Ortiz JR, Englund JA, Neuzil KM

Publication date: 2011

Intervention Analysis of Introduction of Rotavirus Vaccine on Hospital Admissions Rates Due to Acute Diarrhea

This article, published in Cadernos de Saúde Pública, examined the impact of rotavirus vaccine on hospitalization rates for acute diarrhea in children younger than five years following the 2006 introduction of the vaccine in Brazil. The results …

Author: Masukawa MLT, Moriwaki AM, Uchimura NS, de Souza EM, Uchimura TT

Publication date: 2014

Intussusception After Rotavirus Vaccines Reported to US VAERS, 2006-2012

This article, published in Pediatrics, describes investigators' assessment of intussusception events reported to the Vaccine Adverse Event Reporting System from 2006 through 2012, following the respective introductions of RotaTeq® (Merck & …

Author: Haber P, Patel M, Pan Y, et al.

Publication date: 2013

Intussusception Following Rotavirus Vaccine Administration: Post-Marketing Surveillance in the National Immunization Program in Australia

This article, published in Vaccine, reports that surveillance conducted following routine rotavirus vaccination in Australia did not find an overall increase in intussusception with use of RotaTeq® (Merck & Co., Inc.) and Rotarix® …

Author: Buttery JP, Danchin MH, Lee KJ, et al.

Publication date: 2011

Page 8 of 20